121 related articles for article (PubMed ID: 1784589)
21. Competitive antagonism by recognized 5-HT2 receptor antagonists at 5-HT1C receptors in pig choroid plexus.
Sahin-Erdemli I; Schoeffter P; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):137-42. PubMed ID: 1944609
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
Bagdy G; Sved AF; Murphy DL; Szemeredi K
Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
[TBL] [Abstract][Full Text] [Related]
23. Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonist.
Rinaldi-Carmona M; Bouaboula M; Congy C; Oury-Donat F; Simiand J; Shire D; Casellas P; Soubrié P; Brelière JC; Le Fur G
Eur J Pharmacol; 1993 Jun; 246(1):73-80. PubMed ID: 8354344
[TBL] [Abstract][Full Text] [Related]
24. Effects of 5-HT receptor subtype-selective drugs on locomotor activity and motor habituation in the DHT adult rat model.
Pranzatelli MR; Jappay E; Snodgrass SR
Pharmacol Biochem Behav; 1987 Jul; 27(3):497-504. PubMed ID: 3116560
[TBL] [Abstract][Full Text] [Related]
25. Evidence for involvement of 5-HT2 and 5-HT1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenyl aminopropane)-2 (DOI).
Pranzatelli MR
Neurosci Lett; 1990 Jul; 115(1):74-80. PubMed ID: 2216059
[TBL] [Abstract][Full Text] [Related]
26. Electrophysiological characterization of 5-hydroxytryptamine2 receptors in the rat medial prefrontal cortex.
Ashby CR; Jiang LH; Kasser RJ; Wang RY
J Pharmacol Exp Ther; 1990 Jan; 252(1):171-8. PubMed ID: 2137174
[TBL] [Abstract][Full Text] [Related]
27. Neonatal organizational effects of the 5-HT2 and 5-HT1A subsystems on adult behavior in the rat.
González MI; Albonetti E; Siddiqui A; Farabollini F; Wilson CA
Pharmacol Biochem Behav; 1996 May; 54(1):195-203. PubMed ID: 8728558
[TBL] [Abstract][Full Text] [Related]
28. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
[TBL] [Abstract][Full Text] [Related]
29. Characterization of flufylline, fluprofylline, ritanserin, butanserin and R 56413 with respect to in-vivo alpha 1-,alpha 2- and 5-HT2-receptor antagonism and in-vitro affinity for alpha 1-,alpha 2- and 5-HT2-receptors: comparison with ketanserin.
Korstanje C; Sprenkels R; Doods HN; Hugtenburg JG; Boddeke E; Batink HD; Thoolen MJ; Van Zwieten PA
J Pharm Pharmacol; 1986 May; 38(5):374-9. PubMed ID: 2872314
[TBL] [Abstract][Full Text] [Related]
30. Do functional relationships exist between 5-HT1A and 5-HT2 receptors?
Darmani NA; Martin BR; Pandey U; Glennon RA
Pharmacol Biochem Behav; 1990 Aug; 36(4):901-6. PubMed ID: 2145593
[TBL] [Abstract][Full Text] [Related]
31. Ketanserin and ritanserin can reduce reperfusion-induced but not ischaemia-induced arrhythmias in anaesthetised rats.
Coker SJ; Ellis AM
J Cardiovasc Pharmacol; 1987 Oct; 10(4):479-84. PubMed ID: 2444803
[TBL] [Abstract][Full Text] [Related]
32. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors.
Backus LI; Sharp T; Grahame-Smith DG
Br J Pharmacol; 1990 Aug; 100(4):793-9. PubMed ID: 2145051
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.
Bagdy G; Kalogeras KT
Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526
[TBL] [Abstract][Full Text] [Related]
34. Serotonin antagonist pirenperone inhibits sexual behavior in the male rat: attenuation by quipazine.
Mendelson SD; Gorzalka BB
Pharmacol Biochem Behav; 1985 Apr; 22(4):565-71. PubMed ID: 3158005
[TBL] [Abstract][Full Text] [Related]
35. Ritanserin blocks DOI-altered embryonic motility and posthatch learning in the developing chicken.
Bollweg G; Sparber S
Pharmacol Biochem Behav; 1996 Nov; 55(3):397-403. PubMed ID: 8951981
[TBL] [Abstract][Full Text] [Related]
36. Involvement of 5-HT2 receptors in the wet-dog shake behaviour induced by 5-hydroxytryptophan in the rat.
Yap CY; Taylor DA
Neuropharmacology; 1983 Jul; 22(7):801-4. PubMed ID: 6604883
[TBL] [Abstract][Full Text] [Related]
37. Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism.
Cohen ML; Bloomquist WL; Snoddy HD; Fuller RW
Life Sci; 1989; 45(13):1185-9. PubMed ID: 2507847
[TBL] [Abstract][Full Text] [Related]
38. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
Lucki I; Nobler MS; Frazer A
J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
[TBL] [Abstract][Full Text] [Related]
39. Effects of ketanserin on DOI-, MCPP- and TRH-induced prolactin secretion in estrogen-treated rats.
Pan JT; Tai MH
Life Sci; 1992; 51(11):839-45. PubMed ID: 1522746
[TBL] [Abstract][Full Text] [Related]
40. Assessment of affinity and dissociation ability of a newly synthesized 5-HT2 antagonist, AT-1015: comparison with other 5-HT2 antagonists.
Rashid M; Watanabe M; Nakazawa M; Nakamura T; Hattori K; Nagatom T
Jpn J Pharmacol; 2001 Nov; 87(3):189-94. PubMed ID: 11885967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
